AVAH Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

621.53M

+19.56%

0.122

+143.14%

619.51M

+10.78%

0.133

+33.28%

635.13M

+7.73%

0.146

-18.99%

Estimates Revision

The market is revising Upward the revenue expectations for Aveanna Healthcare Holdings Inc. (AVAH) for FY2025, with the revenue forecasts being adjusted by 3.54% over the past three months. During the same period, the stock price has changed by 0.28%.

Revenue Estimates for FY2025

Revise Upward

+3.54%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+26.2%

In Past 3 Month

Stock Price

Go Up

+0.28%

In Past 3 Month

8 Analyst Rating

Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is 10.44 USD with a low forecast of 9.00 USD and a high forecast of 12.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

4 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

9.00

Averages

10.44

High

12.50

Current: 0.000

Low

9.00

Averages

10.44

High

12.50

BMO Capital

Outperform

initiated

$11

2025-11-12

Reason

BMO Capital

Price Target

$11

2025-11-12

initiated

Outperform

Reason

BMO Capital initiated coverage of Aveanna with an Outperform rating and $11 price target. Shares are up about 130% since early August on strong Q2 and Q3 results fueled by state reimbursement increases, preferred payer expansion, and disciplined cost control, which also lowered leverage, the analyst tells investors in a research note. While future Medicaid rate hikes may be limited, ongoing payer conversions, cost discipline, and potential M&A underpin expectations for 10+ long-term EBITDA growth, the firm says.

UBS

AJ Rice

Neutral

maintain

2025-11-07

Reason

UBS

AJ Rice

Price Target

2025-11-07

maintain

Neutral

Reason

UBS analyst AJ Rice raised the firm's price target on Aveanna to $9.50 from $9 and keeps a Neutral rating on the shares.

Jefferies

Buy

maintain

$11

2025-10-28

Reason

Jefferies

Price Target

$11

2025-10-28

maintain

Buy

Reason

Jefferies raised the firm's price target on Aveanna to $12.50 from $11 and keeps a Buy rating on the shares after the company announced a secondary offering of 10M shares along with preliminary Q3 results last week. The preliminary results reflect management's success in securing favorable reimbursement, driving volume and EBITDA growth, the analyst tells investors.

RBC Capital

Ben Hendrix

Sector Perform

maintain

$8 -> $10

2025-10-23

Reason

RBC Capital

Ben Hendrix

Price Target

$8 -> $10

2025-10-23

maintain

Sector Perform

Reason

RBC Capital analyst Ben Hendrix raised the firm's price target on Aveanna to $10 from $8 and keeps a Sector Perform rating on the shares. The company reported strong preliminary Q3 results that came in well ahead of expectations, the analyst tells investors in a research note. The firm also believes J.H. Whitney's recently priced sale of 10M shares should begin to ease the stock's private equity and share liquidity overhang.

Truist

Hold

upgrade

2025-10-14

Reason

Truist

Price Target

2025-10-14

upgrade

Hold

Reason

Truist raised the firm's price target on Aveanna to $9.50 from $6.50 and keeps a Hold rating on the shares as part of a broader research note previewing Q3 results in Healthcare Service. The firm is "broadly bullish" on the industry as it expects ongoing strength in core demand drivers and continues to like the long-term positioning of covered names within their sector verticals, coupled with improved visibility around the regulatory environment, the analyst tells investors in a research note. Strong free cash flows and attractive financial flexibility across the bulk of the sector underpins the ongoing growth investment, Truist notes, adding that it sees a "brisk opportunity" to deploy capital to further augment core growth and drive M&A.

JPMorgan

Underweight -> Neutral

upgrade

$6 -> $10

2025-09-18

Reason

JPMorgan

Price Target

$6 -> $10

2025-09-18

upgrade

Underweight -> Neutral

Reason

JPMorgan upgraded Aveanna to Neutral from Underweight with a price target of $10, up from $6, after assuming coverage of the name. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. Aveanna's value proposition represents a \"unique way\" to gain exposure to the shift to home health, but if faces a challenging rate environment and broader reimbursement risk, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH.O) is 14.66, compared to its 5-year average forward P/E of 39.58. For a more detailed relative valuation and DCF analysis to assess Aveanna Healthcare Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

39.58

Current PE

14.66

Overvalued PE

145.45

Undervalued PE

-66.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.43

Current EV/EBITDA

9.87

Overvalued EV/EBITDA

14.15

Undervalued EV/EBITDA

10.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.42

Current PS

0.67

Overvalued PS

0.71

Undervalued PS

0.13

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

AVAH News & Events

Events Timeline

No data

News

5.0

00:06 AMFool

Aveanna Healthcare's CCO Sells 36,015 Shares for $292,488 Amid Turnaround

5.0

00:04 AMNASDAQ.COM

Aveanna Healthcare Executive Sells 36,015 Shares for $292,488

2.0

01-02NASDAQ.COM

Aveanna Healthcare (AVAH) Shares Drop to $7.68, RSI at 28 Indicates Oversold Condition

People Also Watch

Frequently Asked Questions

What is Aveanna Healthcare Holdings Inc (AVAH) stock price today?

The current price of AVAH is 8.975 USD — it has increased 1.18 % in the last trading day.

What is Aveanna Healthcare Holdings Inc (AVAH)'s business?

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.

What is the price predicton of AVAH Stock?

What is Aveanna Healthcare Holdings Inc (AVAH)'s revenue for the last quarter?

Aveanna Healthcare Holdings Inc revenue for the last quarter amounts to 621.94M USD, increased 22.18 % YoY.

What is Aveanna Healthcare Holdings Inc (AVAH)'s earnings per share (EPS) for the last quarter?

Aveanna Healthcare Holdings Inc. EPS for the last quarter amounts to 0.06 USD, decreased -127.27 % YoY.

What changes have occurred in the market's expectations for Aveanna Healthcare Holdings Inc (AVAH)'s fundamentals?

How many employees does Aveanna Healthcare Holdings Inc (AVAH). have?

Aveanna Healthcare Holdings Inc (AVAH) has 3500 emplpoyees as of January 08 2026.

What is Aveanna Healthcare Holdings Inc (AVAH) market cap?

Today AVAH has the market capitalization of 1.85B USD.